Tandem Diabetes Care (TNDM) Net Margin Growth (1y) (2014 - 2026)
Tandem Diabetes Care (TNDM) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 67.00 |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 1,344.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,344.00 |
| Mar 31, 2026 | 4,746.00 |
| Dec 31, 2025 | -45.00 |
| Sep 30, 2025 | 102.00 |
| Jun 30, 2025 | -790.00 |
| Mar 31, 2025 | -3,342.00 |
| Dec 31, 2024 | 1,549.00 |
| Sep 30, 2024 | 824.00 |
| Jun 30, 2024 | 436.00 |
| Mar 31, 2024 | 5,086.00 |
| Dec 31, 2023 | -802.00 |
| Sep 30, 2023 | 617.00 |
| Jun 30, 2023 | -1,073.00 |
| Mar 31, 2023 | -6,477.00 |
| Dec 31, 2022 | -1,233.00 |
| Sep 30, 2022 | -2,713.00 |
| Jun 30, 2022 | -984.00 |
| Mar 31, 2022 | -476.00 |
| Dec 31, 2021 | -500.00 |
| Sep 30, 2021 | 1,081.00 |